OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 315107Active ingredients:
Semaglutide
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800668626
|
From
15 Apr 2022
to
31 Dec 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
A TGA web statement is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/ozempic-semaglutide-shortage. Unregistered products have been approved for supply under Section 19A. The following approval holders can be contacted for details on supply: Medsurge Pty Ltd - 1300 788 261 or sales@medsurge.com.au
|